User Agreement

Important Information – Please Read


By accessing and using this document, you are agreeing to the following terms and conditions and all applicable laws.

These documents provide information on the results of certain drug studies initiated on or after October 15, 2002 sponsored or conducted by URL Pharma or its subsidiaries or affiliates. The nature and purpose of this document is to comply with certain applicable laws and is non-promotional.

Product information provided in these documents may differ with other published data due to the limited scope of the information published here. In case of doubt, please refer to the prescribing information approved by the FDA.


No Medical Advice Included


Patients: Nothing in these documents should be construed as the giving of medical advice or the making of a recommendation. These documents should not be relied on as the basis for any decision or action or replace medical advice, medical visits or recommendations from health care providers. Any questions regarding the information in these documents should be directed to your physician.


Healthcare Providers: This is not a prescription consultation service. The information in these documents is not prescribing information, and prescribing decisions should always refer to the specific labeling information approved by the FDA.


No Representation or Warranty, No Liability


While URL Pharma uses reasonable efforts to provide accurate information in these documents, everything in these documents is provided “AS IS”. URL Pharma does not make, and expressly disclaims, any representations or warranties of any kind, either express or implied (including without limitation any implied warranties of merchantability, fitness for a particular purpose or non-infringement) with regard to any such information, its accuracy or completeness or the frequency that it is updated. URL Pharma assumes no liability or responsibility for any errors or omissions in the content of these documents and your use of this document is at your own risk. URL Pharma (including its officers, directors, employees or affiliates) shall not be liable for any damages of any kind or any claims or losses, resulting from or in connection with the creation or use of, or reliance on, this document.


Impermissible Use


These documents do not confer rights in any trademarks and service marks used in these documents, whether owned by URL Pharma or others. The results data provided in these documents are the property of URL Pharma and may not be copied, transcribed, published or otherwise used, without written permission.


Applicable Law


These terms and conditions shall be governed by and construed in accordance with the laws of the State of Pennsylvania, without regard to its choice of law principles

  • Home
  • About us
  • Generic Division
  • Technology
  • Contact Us
  • Brand Division
  • News Room
Making a World of Difference

Site Map

Skip Navigation Links.
Qualaquin® Qualaquin®
Proprietary Pipeline/ Research and Development Proprietary Pipeline/ Research and Development
AR Scientific® AR Scientific®
Clinical Trials Clinical Trials
FIBRICOR® (fenofibric acid) tablets FIBRICOR® (fenofibric acid) tablets
Authorized Distributors Authorized Distributors
Home

About us
History
Mission / Strategy
Privacy Policy
Terms of Use
Overview
People
Corporate Compliance
Code of Conduct
Verified-Accredited Wholesale Distributor (VAWD)


Generic Division
Product Catalog
Licensing
Research and Development
Sales Information and Customer Service
Clinical Trials
Authorized Distributors

Technology
PRISM™
NanoBurst™
MultiBurst™
Z-Burst™
Patents
In-Licensing/ Partnering
Project Execution
Partners


Contact Us
Directions
Return Policy
Health Care Professionals

Brand Division
Qualaquin®
Proprietary Pipeline/ Research and Development
AR Scientific®
Clinical Trials
FIBRICOR® (fenofibric acid) tablets
Authorized Distributors


Contract Manufacturing

Research and Development


Unapproved Drugs Resource Center
Unapproved Drugs
FDA Unapproved Drugs Initiative
New England Journal of Medicine
Wall Street Journal
American College of Rheumatology
Arthritis Today
National Minority Quality Forum
Men's Health Network
MANA
American Pharmacists Association
National Association of Boards of Pharmacy
New Jersey Consumer Affairs
Providence Health Plans
CNNHealth.com Report on Unapproved Drugs
Opinion Articles
Latino Times
Keep Seniors Safe
LegitScript
URL Pharma Update to FDA
Los Angeles Times

PDF Library


News Room

Careers
Benefits & Compensation
Equal Opportunity Statement

© 2008 Site designed by Arise Productions. Email webmaster@urlpharma.com for technical information.
Site Map   URL Pharma™ is a trademark of URL Pharma, Inc.